DexCom
DXCM
79.32
-0.87
-1.08%
DexCom
US · DXCM
#635 by market cap
Listed 2005
79.32
-0.87
-1.08%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
A
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Improving
2
■ Upgrades■ Downgrades
- 2 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: Barclays moved from Hold to Buy on 2026-10-07.
Analyst consensus 15 analysts
Buy
Avg price target 99.21 +25.1%
Price target rangecurrent 79.32
Low85.00
Avg99.21
High120.00
Buy 93%
Hold 7%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-18 | BofA Securities | -- | Buy | -- |
| 2026-10-30 | TD Cowen | -- | Buy | 95.00 |
| 2026-10-30 | CCORF | -- | Buy | 97.00 |
| 2026-10-30 | UBS | -- | Buy | 107.00 |
| 2026-10-30 | Piper Sandler | -- | Buy | 95.00 |
| 2026-10-30 | Raymond James | -- | Buy | 97.00 |
| 2026-10-30 | Stifel | -- | Buy | 95.00 |
| 2026-10-30 | Barclays | -- | Buy | 120.00 |
| 2026-10-30 | J.P. Morgan | -- | Hold | 85.00 |
| 2026-10-29 | RBC Capital | -- | Buy | 105.00 |
| 2026-10-23 | BofA Securities | -- | Buy | -- |
| 2026-10-21 | Citi | -- | Buy | 105.00 |
| 2026-10-14 | Wells Fargo | -- | Buy | 90.00 |
| 2026-10-14 | Citi | -- | Buy | 105.00 |
| 2026-10-13 | Mizuho Securities | -- | Buy | 100.00 |
| 2026-10-12 | BTIG | -- | Buy | 96.00 |
| 2026-10-07 | Barclays | -- | Buy | 115.00 |
| 2026-10-05 | Citi | -- | Buy | 105.00 |
| 2026-10-01 | RBC Capital | -- | Buy | 105.00 |
| 2026-09-29 | Wells Fargo | -- | Buy | 90.00 |
| 2026-09-23 | Truist Financial | -- | Buy | 102.00 |
| 2026-09-18 | TD Cowen | -- | Buy | 95.00 |
| 2026-09-18 | Truist Financial | -- | Buy | 102.00 |
| 2026-09-09 | Wells Fargo | -- | Buy | 90.00 |
| 2026-08-14 | Citi | -- | Buy | 105.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-07 | Barclays | Hold → Buy | 115.00 |
| 2025-12-02 | Morgan Stanley | Hold → Buy | 75.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-29 | After close | ±9.44% | +2.95% (in line) |
| 2026/Q2 | 2026-07-30 | After close | ±9.48% | +11.95% (beat) |
| 2026/Q1 | 2026-04-30 | After close | ±10.79% | +3.02% (in line) |
| 2025/Q4 | 2026-02-12 | After close | ±11.60% | +7.59% (in line) |
| 2025/Q3 | 2025-10-30 | After close | ±16.01% | -14.63% (in line) |
| 2025/Q2 | 2025-07-30 | After close | ±9.84% | -9.31% (in line) |
| 2025/Q1 | 2025-05-01 | After close | ±11.62% | +16.17% (beat) |
| 2024/Q4 | 2025-02-13 | After close | ±10.25% | +5.92% (in line) |
| 2024/Q3 | 2024-10-24 | After close | ±13.48% | -1.88% (in line) |
| 2024/Q2 | 2024-07-25 | After close | ±12.10% | -40.66% (beat) |
| 2023/Q4 | 2024-02-08 | After close | ±8.30% | -5.18% (in line) |
| 2023/Q3 | 2023-10-26 | After close | ±14.75% | +10.11% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:21 · For reference only, not investment advice and not tailored to your situation.
DexCom discussion 0 comments